Abstract:Our findings provide an efficient combination strategy for increasing clinically important daptomycin production by enhancing aspartate precursor supply, abolishing by‐product red pigment production, engineering daptomycin biosynthetic gene cluster (BGC) by promoter replacement, and duplicating the engineered daptomycin BGC in Streptomyces roseosporus wild‐type strain. We finally obtained a maximal DAP titre of 350.7 μg/mL, representing the highest reported titre in shake‐flask fermentation. Such strategies can be readily applied in the overproduction of other antibiotics using aspartate as a precursor. Daptomycin (DAP), a novel cyclic lipopeptide antibiotic produced by Streptomyces roseosporus, is clinically important for treatment of infections caused by multidrug‐resistant Gram‐positive pathogens, but the low yield hampers its large‐scale industrial production. Here, we describe a combination metabolic engineering strategy for constructing a DAP high‐yielding strain. Initially, we enhanced aspartate (Asp) precursor supply in S. roseosporus wild‐type (WT) strain by separately inhibiting Asp degradation and competitive pathway genes using CRISPRi and overexpressing Asp synthetic pathway genes using strong promoter kasOp*. The resulting strains all showed increased DAP titre. Combined inhibition of acsA4, pta, pyrB, and pyrC increased DAP titre to 167.4 μg/mL (73.5% higher than WT value). Co‐overexpression of aspC, gdhA, ppc, and ecaA led to DAP titre 168 μg/mL (75.7% higher than WT value). Concurrently, we constructed a chassis strain favourable for DAP production by abolishing by‐product production (i.e., deleting a 21.1 kb region of the red pigment biosynthetic gene cluster (BGC)) and engineering the DAP BGC (i.e., replacing its native dptEp with kasOp*). Titre for the resulting chassis strain reached 185.8 μg/mL. Application of our Asp precursor supply strategies to the chassis strain further increased DAP titre to 302 μg/mL (2.1‐fold higher than WT value). Subsequently, we cloned the engineered DAP BGC and duplicated it in the chassis strain, leading to DAP titre 274.6 μg/mL. The above strategies, in combination, resulted in maximal DAP titre 350.7 μg/mL (2.6‐fold higher than WT value), representing the highest reported DAP titre in shake‐flask fermentation. These findings provide an efficient combination strategy for increasing DAP production and can also be readily applied in the overproduction of other Asp‐related antibiotics.

Degradation Mechanism of AtrA Mediated by ClpXP and Its Application in Daptomycin Production in Streptomyces Roseosporus.

Transcriptional Regulation of the Daptomycin Gene Cluster in Streptomyces Roseosporus by an Autoregulator, AtrA.

Dual Regulation Between the Two-Component System PhoRP and AdpA Regulates Antibiotic Production in Streptomyces

Identification of Two Novel Regulatory Genes Involved in Pristinamycin Biosynthesis and Elucidation of the Mechanism for AtrA-p-mediated Regulation in Streptomyces Pristinaespiralis

DepR1, a TetR Family Transcriptional Regulator, Positively Regulates Daptomycin Production in an Industrial Producer, Streptomyces Roseosporus SW0702

Metabolic engineering of Streptomyces roseosporus for increased production of clinically important antibiotic daptomycin

Daptomycin production enhancement by ARTP mutagenesis and fermentation optimization in Streptomyces roseosporus

Regulation of daptomycin biosynthesis in Streptomyces roseosporus: new insights from genomic analysis and synthetic biology to accelerate lipopeptide discovery and commercial production

Transposon-based Identification of a Negative Regulator for the Antibiotic Hyper-Production in Streptomyces

Improving the Yield and Quality of Daptomycin in Streptomyces Roseosporus by Multilevel Metabolic Engineering

A novel strategy of gene screen based on multi-omics in Streptomyces roseosporus

Degradation Mechanism of AAA+ Proteases and Regulation of Streptomyces Metabolism

Metabolic adjustments in response to ATP spilling by the small DX protein in a Streptomyces strain

Negative Regulation of Daptomycin Production by DepR2, an ArsR-family Transcriptional Factor.

The faucet knob effect of DptE crotonylation on the initial flow of daptomycin biosynthesis

Strain Improvement of Streptomyces Roseosporus for Daptomycin Production by Rational Screening of He–Ne Laser and NTG Induced Mutants and Kinetic Modeling

Regulatory and Biosynthetic Effects of the Bkd Gene Clusters on the Production of Daptomycin and Its Analogs A21978C 1–3

Pleiotropic regulation of daptomycin synthesis by DptR1, a LuxR family transcriptional regulator

Efficient bioconversion of daptomycin to its nucleus by heterologous expression of deacylase genes in Streptomyces

A meet-up of acetyl phosphate and c-di-GMP modulates BldD activity for development and antibiotic production

Dual Positive Feedback Regulation of Protein Degradation of an Extra-cytoplasmic Function Σ Factor for Cell Differentiation in Streptomyces Coelicolor